Avalanche Biotechnologies Inc (ADVM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

800 SAGINAW DRIVE REDWOOD CITY, CA 94063

Avalanche Biotechnologies Inc. develops gene therapies for the treatment of ophthalmologic disorders. The Company creates therapeutic protein for treatments of eye disease. Avalanche operates in the United States.

Data as of 2020-05-30
Market Cap1.65 Billion Shares Outstanding79.974 Million Avg 30-day Volume1.494 Million
P/E Ratio Dividend Yield EPS-1.01
Price/Sales6625.99 Price cash flow ratio242.9 Price free cash flow ratio-30.7
Book Value2.19 Price to Tangible Book9.29 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.121701
BETA2.331 52-week High/Low23.7899 / 4.96 Stddev0.285642
View SEC Filings from ADVM instead.

View recent insider trading info

 
Avalanche Biotechnologies Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Check out our reporting and analysis

Funds Holding ADVM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADVM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

65 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

88.3 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COUNTOURIOTIS ATHENA PRESIDENT & CEO

  • Officer
  • Director
 26,872 2020-05-21 0

GASMI MEHDI

  • Director
 274,442 2020-05-20 7

MCLAUGHLIN JOHN PETER

  • Director
 86,974 2020-05-18 0

BLUMENKRANZ MARK S.

  • Director
 0 2020-05-14 0

PATTERSON LEONE D CEO, PRESIDENT AND DIRECTOR

  • Officer
  • Director
 123,659 2020-05-06 8

SCOPA JAMES PAUL

  • Director
 53,334 2020-05-04 4

WHITCUP SCOTT M

  • Director
 0 2020-04-16 2

SALZMAN AMBER

  • Director
 0 2020-04-13 0

HEMRAJANI REKHA

  • SEE REMARKS
 14,250 2020-04-08 2

WOIWODE THOMAS

  • Director
  • 10% Owner
 4,959,769 2020-03-03 1

THEDINGA ANGELA CHIEF TECHNOLOGY OFFICER

  • Officer
 0 2020-02-21 2

OSBORNE AARON CHIEF MEDICAL OFFICER

  • Officer
 0 2020-02-20 1

LEUNG THOMAS CHIEF FINANCIAL OFFICER

  • Officer
 0 2020-02-20 1

SOPARKAR PETER CHIEF LEGAL OFFICER

  • Officer
 0 2020-02-20 3

GUERIN JOHN PATRICK ET AL

  • Director
  • 10% Owner
 173,513 2020-01-02 0

MACHADO PATRICK

  • Director
 0 2020-01-01 2

CLEVELAND PAUL B

  • Director
 0 2019-10-22 0

LUPHER, JR. MARK L.

  • Director
 0 2019-08-15 2

FINER MITCHELL H.

  • Director
 0 2019-07-31 2

SPIVEY RICHARD N.

  • Director
 0 2019-07-31 1

CARTER ERIC G

  • Director
 0 2019-07-31 1

CHENG JENNIFER C. GENERAL COUNSEL

  • Officer
 0 2019-02-14 0

WACHTER PAUL

0 2018-06-14 0

SCHWARTZ STEVEN DANIEL

  • Director
 398,991 2017-06-12 0

BARONE SAMUEL B. SVP, CLINICAL DEVELOPMENT

  • Officer
 172,335 2017-02-09 0

RUSSO CARLO EVP AND CHIEF MEDICAL OFFICER

  • Officer
 0 2016-05-11 0

VERSANT VENTURES IV, LLC

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT IV LUXCO S.A R.L.

VERSANT CAPITAL IV (SWITZERLAND) GMBH

  • 10% Owner
 7,003,892 2016-05-11 0

RUBIO ROMAN G. SVP, TRANSLATIONAL MEDICINE

  • Officer
 165,650 2016-02-12 0

BRAUN SHIRLEY VP, HUMAN RESOURCES

  • Officer
 161,140 2016-02-12 0

SWARTZBURG MICHAEL PRINCIPAL ACCOUNTING OFFICER

  • Officer
 82,113 2016-02-12 0

BAIN LINDA CHIEF FINANCIAL OFFICER

  • Officer
 41,930 2015-08-21 0

HULL HANS CHIEF EXECUTIVE OFFICER

  • Officer
 137,210 2015-08-21 0

CHALBERG THOMAS W. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 1,099,401 2015-06-10 0

ZYGTECH, LLC

  • 10% Owner
 No longer subject to file 2015-04-13 0

REGENERON PHARMACEUTICALS INC

  • 10% Owner
 No longer subject to file 2014-08-05 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
 No longer subject to file 2014-08-05 0

VENROCK ASSOCIATES VI, L.P.

VENROCK PARTNERS VI, L.P.

VENROCK MANAGEMENT VI, LLC

VENROCK PARTNERS MANAGEMENT VI, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

HOVE ANDERS D

KOH BONG Y

  • 10% Owner
 2,365,471 2014-08-05 0

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

  • 10% Owner
 2,365,471 2014-08-05 0

VENROCK ASSOCIATES VI, L.P.

VENROCK PARTNERS VI, L.P.

VENROCK MANAGEMENT VI, LLC

VENROCK PARTNERS MANAGEMENT VI, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS LP

VHCP CO-INVESTMENT HOLDINGS, LLC

VHCP MANAGEMENT, LLC

ROBERTS BRYAN E

HOVE ANDERS D

  • 10% Owner
 0 2014-07-30 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 0 2014-07-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GASMI MEHDI - Director

2020-05-21 S 3,599 $20.02 a 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-21 M 3,599 d 128,000 274,442.00 direct

GASMI MEHDI - Director

2020-05-21 M 3,599 $4.80 a 278,041 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 M 1,401 d 131,599 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 S 1,401 $20.01 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-20 M 1,401 $4.80 a 275,843 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 S 4,700 $18.11 d 274,742 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 M 5,000 $4.80 a 279,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 M 5,000 d 133,000 274,442.00 direct

GASMI MEHDI - Director

2020-05-18 S 300 $19.03 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-06 M 25,000 d 138,000 274,442.00 direct

GASMI MEHDI - Director

2020-05-06 M 25,000 $4.80 a 299,442 274,442.00 direct

PATTERSON LEONE D - Director - Officer CEO, PRESIDENT AND DIRECTOR

2020-05-06 M 20,000 d 155,576 123,659.00 direct

PATTERSON LEONE D - Director - Officer CEO, PRESIDENT AND DIRECTOR

2020-05-06 S 20,000 $20.02 d 123,659 123,659.00 direct yes

GASMI MEHDI - Director

2020-05-06 S 25,000 $20.03 d 274,442 274,442.00 direct

PATTERSON LEONE D - Director - Officer CEO, PRESIDENT AND DIRECTOR

2020-05-06 M 20,000 $3.44 a 143,659 123,659.00 direct

GASMI MEHDI - Director

2020-05-05 M 10,000 d 163,000 274,442.00 direct

GASMI MEHDI - Director

2020-05-05 S 10,000 $16.26 d 274,442 274,442.00 direct

GASMI MEHDI - Director

2020-05-05 M 10,000 $4.80 a 284,442 274,442.00 direct

SCOPA JAMES PAUL - Director

2020-05-04 M 23,334 d 46,666 53,334.00 direct

SCOPA JAMES PAUL - Director by trust

2020-05-04 M 23,334 $6.48 a 53,334 53,334.00 indirect

WHITCUP SCOTT M - Director

2020-04-16 A 60,000 a 60,000 0.00 direct

Elevate your investments